scispace - formally typeset
B

Beth E. P. Henderson

Researcher at University of Edinburgh

Publications -  20
Citations -  1475

Beth E. P. Henderson is an academic researcher from University of Edinburgh. The author has contributed to research in topics: Progenitor cell & Transcriptome. The author has an hindex of 13, co-authored 19 publications receiving 775 citations. Previous affiliations of Beth E. P. Henderson include University of Southern California & United States Department of the Army.

Papers
More filters
Journal ArticleDOI

Single-cell transcriptome analyses reveal novel targets modulating cardiac neovascularization by resident endothelial cells following myocardial infarction

TL;DR: A single-cell gene expression atlas of cardiac specific resident ECs, and the transcriptional hierarchy underpinning endogenous vascular repair following MI are presented, which provide a rich resource that could assist in the development of new therapeutic interventions to augment endogenous myocardial perfusion and enhance regeneration in the injured heart.
Journal ArticleDOI

Stromal Cells Covering Omental Fat-Associated Lymphoid Clusters Trigger Formation of Neutrophil Aggregates to Capture Peritoneal Contaminants.

TL;DR: The omentum is a visceral adipose tissue rich in fat-associated lymphoid clusters (FALCs) that collects peritoneal contaminants and provides a first layer of immunological defense within the abdomen, and inhibition of protein arginine deiminase 4, an enzyme important for the release of neutrophils extracellular traps, abolished neutrophil aggregation and the capture of peritoneAL contaminants by omental FALCs.
Journal ArticleDOI

Co-delivery of a laminin-111 supplemented hyaluronic acid based hydrogel with minced muscle graft in the treatment of volumetric muscle loss injury.

TL;DR: Functional recovery mediated by the combination therapy is likely due to a superposition of de novo muscle fiber regeneration and augmented repair of muscle fibers within the remaining musculature, and the capacity for VML therapies to augment regeneration and repair within the remain musculatures may have significant clinical impact and warrants further exploration.